EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intraoperative Flow Cytometry Upon and Beyond the Cell Cycle: A Case Study of the Characterization of a Bone Metastasis

Georgios S. Markopoulos, Emilios E. Pakos, Vasilios Gavrielatos, Dimitrios Kosmas, Ioannis Gkiatas, George A. Alexiou, Anna Batistatou, Evangeli Lampri, George Vartholomatos

Journal of Molecular Pathology · 25.10.2023 · 4 (4) · 225-233

DOI: 10.3390/jmp4040020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Pathology, online erschienen am 25.10.2023. Verfasst von Georgios S. Markopoulos und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accurate assessment of malignancy and the precise characterization of cancer type are pivotal in guiding clinical decisions and ensuring optimal patient outcomes. The challenging task of identifying the primary site of carcinoma, especially during a surgical procedure, is not always possible and necessitates the exploration of novel, innovative diagnostic techniques. In this report, we detail a unique case of carcinoma of unknown primary origin encountered during an orthopedic surgical procedure. We introduce a novel intraoperative flow cytometry (iFC) methodology, distinctly different from traditional flow cytometry, which is tailored for real-time assessment during surgeries. This iFC technique, applied in a bone metastasis case of unknown primary origin, enabled DNA content analysis and the quantification of cytokeratin for rapid malignancy characterization, presenting an avenue for immediate surgical guidance and decision making. The case was distinctively characterized using iFC, shedding light on the potential of this emerging technique. iFC has been gaining traction because of its ability to facilitate cancer cell assessment and margin evaluation. It has been successfully applied across a wide spectrum of neoplastic conditions. Our innovative, two-step approach using iFC encompasses (1) DNA content analysis, which serves as a reliable indicator for the detection of cancer cells, and (2) the quantification of cytokeratin, a pivotal marker, which aids in the characterization and classification of a malignancy. In this case, the malignancy was classified as a carcinoma. The findings obtained from iFC were subsequently validated through pathology assessment, confirming the accuracy and reliability of our approach. This noteworthy case strengthens the potential of iFC as a novel tool in malignancy assessment, which is not just limited to cell cycle analysis but instead extends beyond this application. The promising results obtained from this case study serve as a testament to the need for more extensive research in clinical studies.

Zitieren

APA

Markopoulos, G. S., Pakos, E. E., Gavrielatos, V., Kosmas, D., Gkiatas, I., Alexiou, G. A., Batistatou, A., Lampri, E., & Vartholomatos, G. (2023). Intraoperative Flow Cytometry Upon and Beyond the Cell Cycle: A Case Study of the Characterization of a Bone Metastasis. Journal of Molecular Pathology, 4(4), 225-233. https://doi.org/10.3390/jmp4040020

Vancouver

Markopoulos GS, Pakos EE, Gavrielatos V, Kosmas D, Gkiatas I, Alexiou GA, et al. Intraoperative Flow Cytometry Upon and Beyond the Cell Cycle: A Case Study of the Characterization of a Bone Metastasis. Journal of Molecular Pathology. 2023;4(4):225-233. doi:10.3390/jmp4040020

BibTeX
@article{Markopoulos2023,
  author = {Markopoulos, Georgios S. and Pakos, Emilios E. and Gavrielatos, Vasilios and Kosmas, Dimitrios and Gkiatas, Ioannis and Alexiou, George A. and Batistatou, Anna and Lampri, Evangeli and Vartholomatos, George},
  title = {Intraoperative Flow Cytometry Upon and Beyond the Cell Cycle: A Case Study of the Characterization of a Bone Metastasis},
  journal = {Journal of Molecular Pathology},
  year = {2023},
  volume = {4},
  number = {4},
  pages = {225--233},
  doi = {10.3390/jmp4040020}
}
Kostenlos starten →